Munich Re reported record first-half 2026 net income of €3.925 billion on August 7, then cut full-year reinsurance revenue guidance to €38 billion from €40 billion. July 1 renewal volume fell 9.1% to €2.9 billion on a risk-adjusted price decline of 5.5% (Reinsurance News, August 2026).
A record half-year usually invites a reinsurer to defend share. Munich Re let €2 billion of expected revenue go instead.
Key Takeaways
- Property and casualty excess-of-loss volumes each fell more than 20% at the July date, the sharpest contraction anywhere in the book, while Munich Re found room to grow in proportional business.
- The 5.5% risk-adjusted decline breaks into a 4.4% nominal price fall and a 1.1% business-mix effect, the steepest single renewal of the year after a 3.1% cumulative decline across January and April.
- The reported Q2 combined ratio of 68.9% is a benign-catastrophe number. Major-loss expenditure of €191 million was 4.9% of net insurance revenue against a long-run expected 18%.
- Munich Re's own normalized combined ratio came in near 82%, above the roughly 80% full-year guidance, which is a supporting reason to hold price rather than defend volume.
- Solvency stood at 304% against a roughly 200% comfort level, so nothing in the capital position required writing the business that was walked away from.
What Actually Renewed on July 1
Munich Re's July book, concentrated in North American, South American and Australian casualty and property treaties plus global accounts, renewed at €2.9 billion, a 9.1% reduction against the expiring volume up for renewal (Artemis, August 2026). The 5.5% risk-adjusted price decline splits into a nominal change of negative 4.4% and a negative 1.1% mix effect.
The retreat was concentrated rather than general. Property and casualty excess-of-loss volumes each fell more than 20%, while proportional business held up well enough for Munich Re to grow selectively inside the same renewal season.
Group Chair Christoph Jurecka was explicit that nothing broke in the second quarter: "In essence, in July we saw no acceleration in rate softening compared to the April renewals" (Reinsurance News, July 2026). The market has softened steadily across three consecutive dates, and the company judged the current pace no longer worth chasing with volume.
| Metric | Prior Guidance / Prior Year | Revised / Current |
|---|---|---|
| Reinsurance segment revenue guidance (FY2026) | €40.0B | €38.0B |
| Group insurance revenue guidance (FY2026) | €64.0B | €62.0B |
| Full-year net result target | €6.3B | €6.3B (unchanged) |
| H1 net income | €3.178B (H1 2025) | €3.925B (H1 2026) |
| P&C reinsurance combined ratio (Q2) | 61.0% (Q2 2025) | 68.9% (Q2 2026) |
| July renewal volume | — | -9.1% to €2.9B |
| July renewal risk-adjusted price | — | -5.5% |
| Solvency ratio | — | 304% |
What a Record Half Buys: the Right Not to Write
The volume decision is ordinary cycle management applied at unusual scale, and it is affordable because of everything else in the release.
A treaty renewed at a lower risk-adjusted price locks in that margin for the full 12-month period regardless of how losses develop, and it cannot be unwound once bound. Declining preserves capacity and capital for a point in the cycle where price is commensurate with risk. The cost of declining is revenue Munich Re did not need: H1 net income of €3.925 billion against €3.178 billion a year earlier, €2.211 billion of it in Q2, on annualized group return on equity of 25.5% in the quarter and 23% for the half. The €6.3 billion full-year net result target was left unchanged even as revenue guidance fell.
The underwriting numbers argue the same way once normalized. The reported P&C reinsurance combined ratio of 68.9% in Q2, against 61.0% a year earlier, sits on major-loss expenditure of €191 million, or 4.9% of net insurance revenue, against a long-run expected value of 18%. Munich Re's own normalized figure, stripping reserve releases and one-offs, came in near 82%, modestly above the roughly 80% guided for the year (Insurance Business, August 2026). Underlying margin is drifting toward the top of the target range while price falls.
Solvency of 304%, against a roughly 200% comfort level, removes the last reason to write for volume. That latitude is not universal: Swiss Re grew P&C reinsurance volumes roughly 11% across the combined June and July dates on a 4.2% increase in loss assumptions, and Hannover Re grew traditional P&C premium 3.3% at January on a 3.2% risk-adjusted decline. A monoline reinsurer without diversified earnings faces a harder trade between a growth target and margin.
A Program Average Does Not Describe Any Layer
The single figure the market will carry forward from July is the 5.5% risk-adjusted decline. Applied to a cession-cost assumption, that average describes no actual layer in the book.
Proportional treaties give the reinsurer a fixed share of the cedant's premium and losses, so adequacy turns on the ceding commission and the cedant's own underwriting quality, both readable from historical loss ratios. Excess-of-loss layers instead depend on the reinsurer's own view of tail frequency and severity above an attachment point, built from models carrying far more parameter uncertainty. When rate-on-line falls faster than confidence in the tail estimate improves, the excess layer is where the arithmetic fails first, because the reinsurer holds more of the low-frequency, high-severity risk for less premium.
That is why the same renewal produced growth in proportional business and a fifth off both excess-of-loss lines. It also means the softening documented in the aggregate is not evenly distributed across a program's structure. A cedant pricing 2027 cession cost off the headline decline is assuming the largest reinsurer's capacity stays in the market at whatever price clears, in exactly the layers it has been withdrawing from since the April renewal.
Munich Re has said the opposite is its intention, expecting that "favourable price levels as well as improved terms and conditions can be largely upheld" at January 2027 (Artemis, August 2026). A statement like that is only coherent if the withdrawal continues, which makes the gap between the market average and the achievable price on a specific top layer the place a cession-cost assumption goes wrong.
Further Reading
- Munich Re Cuts April Book 18.5% as Cycle Discipline Holds: The April renewal pullback that preceded the July guidance cut.
- Swiss Re's H1 2026 Loss Assumption Increase and Price Decline: How Munich Re's closest peer chose growth over retrenchment at the same renewal dates.
- Munich Re's Ambition 2030 Combined Ratio Target as a Reinsurance Price Floor: The strategic framework behind the company's willingness to shed volume.
- Property Cat Rate-on-Line Down 16%: The Net Cost of Reinsurance for Primary Rates: How to translate renewal-level pricing data into a primary rate filing.
- The Soft Cycle's Cost-of-Capital Threshold for 2027: What level of pricing triggers capacity withdrawal across the broader reinsurance market.
- Hannover Re Banks a €240 Million Buffer Behind an 83.2% Combined Ratio: A peer choosing reserve prudence over Munich Re's volume discipline as the lever to protect margin.
Sources
- Reinsurance News, "Strong investment returns and low losses propel Munich Re to record H1'26" (August 2026) - reinsurancene.ws
- Artemis, "Munich Re pulls-back at July, says prices, T&Cs can be 'largely upheld' at Jan 2027 renewals" (August 2026) - artemis.bm
- Insurance Business, "Munich Re cuts volume on 5.5% P&C pricing decline" (August 2026) - insurancebusinessmag.com
- Reinsurance News, "P&C environment remains attractive, no acceleration in rate softening at July 1: Munich Re CEO" (July 2026) - reinsurancene.ws
- Munich Re, "Munich Re generates record half-year profit of almost €4bn" (August 2026) - munichre.com
- Artemis, "Swiss Re reports challenging reinsurance renewals, but broadly stable T&Cs" (July 2026) - artemis.bm
- Hannover Re, "Hannover Re anticipates continued attractive market environment in 1 January 2026 renewals" (2026) - hannover-re.com